CLOUDBREAK FS
LIVE

Serial Number

98498394

Owner

Element Biosciences, Inc.

Attorney

Samantha C. Markley

Filing Date

Apr 12, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CLOUDBREAK FS Trademark

Serial Number: 98498394

CLOUDBREAK FS is a trademark filed by Element Biosciences, Inc. on April 12, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Element Biosciences, Inc. (35 trademarks)

9880 Campus Point Drive, Suite 210
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

April 12, 2024

Registration Date

Not Registered

Published for Opposition

January 28, 2025

Goods & Services

Computer systems, namely, computer hardware, downloadable and recorded computer software and associated downloadable data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; clinical diagnostic instruments for scientific use, namely, nucleic acid sequencers, imaging devices for nucleic acids and biological molecules and analyzers in the nature of scientific laboratory research instruments for DNA analysis; all of the foregoing for use in connection with genetic, genomic and multi-omic sequencing and/or research, and none of the foregoing for use in the fields of diabetes management, diabetes analyte testing, diabetes monitoring, glucose testing, glucose monitoring, ketone testing, and/or ketone monitoring

Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical medical diagnostic purposes; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for diagnostic medical use and for clinical medical use; diagnostic reagents for clinical or medical laboratory use, for medical or veterinary purposes; reagents and reagent kits, for medical or veterinary purposes, comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for clinical laboratory research use; clinical diagnostic reagents for laboratory use, for medical or veterinary purposes; reagent kits and reagent beads, for medical or veterinary purposes, with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic laboratory purposes; all of the foregoing for use in connection with genetic, genomic and multi-omic sequencing and/or research, and none of the foregoing for use in the fields of diabetes management, diabetes analyte testing, diabetes monitoring, glucose testing, glucose monitoring, ketone testing, and/or ketone monitoring

Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use, other than for medical or veterinary purposes; reagents and reagent kits, other than for medical or veterinary purposes, comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for scientific research use, for diagnostic scientific use, and for clinical laboratory research use; clinical diagnostic reagents for laboratory use, other than for medical or veterinary purposes; reagent kits and reagent beads, other than for medical or veterinary purposes, with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic laboratory purposes; all of the foregoing for use in connection with genetic, genomic and multi-omic sequencing and/or research, and none of the foregoing for use in the fields of diabetes management, diabetes analyte testing, diabetes monitoring, glucose testing, glucose monitoring, ketone testing, and/or ketone monitoring

Clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, imaging devices for biomolecules and analyzers in the nature of flow-based analyzers providing cell and particle analysis, detection, or counting; all of the foregoing for use in connection with genetic, genomic and multi-omic sequencing and/or research, and none of the foregoing for use in the fields of diabetes management, diabetes analyte testing, diabetes monitoring, glucose testing, glucose monitoring, ketone testing, and/or ketone monitoring

Providing reagent sample diagnostic testing services for others for scientific research purposes and scientific research related thereto; clinical diagnostic services for scientific research purposes, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings; providing online non-downloadable computer software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; providing online nondownloadable computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; all of the foregoing for use in connection with genetic, genomic and multi-omic sequencing and/or research, and none of the foregoing for use in the fields of diabetes management, diabetes analyte testing, diabetes monitoring, glucose testing, glucose monitoring, ketone testing, and/or ketone monitoring

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 16, 2025 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 7, 2025 ETOP
POST PUBLICATION AMENDMENT - ENTERED
Jul 30, 2025 CHPB
ASSIGNED TO PETITION STAFF
Jul 30, 2025 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jun 6, 2025 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 24, 2025 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 28, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 28, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 6, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 24, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 23, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 31, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 31, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 31, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 28, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 25, 2024 NWOS
NEW APPLICATION ENTERED
Apr 12, 2024 NWAP